Page 2 - 
Enclosed is a summary of the Interagency Committee meeting held 
on November 4. Here I have listed a number of functions required 
in the implementation of the guidelines. At the next meeting of 
the Interagency Committee, Federal research agencies will discuss 
their activities and their possible role in such implementation. 
I would very much appreciate your organization's perspective on 
the various functions outlined in the enclosed summary. At the 
next meeting of the committee, there will also be reports from 
various regulatory agencies concerning their possible role in the 
regulation of recombinant DNA research. 
Please feel free to call me (496-2433) if you have any questions 
concerning this letter. It would be helpful to receive a response 
from you as soon as possible so that I can share it with the 
committee. As currently planned, the committee is expected to 
have recommendations for the President by mid-January. 
Sincerely yours, 
/s/ 
Donald S. Fredrickson, M.D. 
Director 
Enclosure 
[ 186 ] 
